High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT

To our knowledge, this is the most extensive retrospective study of HDC in PMNSGCTs patients and the first to thoroughly investigate potential predictors of benefit from this treatment. HDC with ASCT may well represent a therapeutic option in patients with PMNSGCTs after the first relapse or even as a front-line program.

Authors

Institutions

Publication Details

Journal
ESMO Open
Published
2024-09-01
DOI
https://doi.org/10.1016/j.esmoop.2024.103692
Citations
7
Primary Topic
Testicular diseases and treatments
Type
article
Field-Weighted Citation Impact
4.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT

Myriam Labopin, Gianantonio Rosti, Jürgen Finke, Ulrike Koehl et al.
7 citations
ESMO Open
Testicular diseases and treatments
4.01
article

High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT

Myriam Labopin, Gianantonio Rosti, Jürgen Finke, Ulrike Koehl, Simona Secondino, Alessia Pagani, Florent Malard, Jurgen H. E. Kuball, Paolo Pedrazzoli, Manuela Badoglio, Ugo De Giorgi, Christos Kosmas, Christoph Seidel, Carsten Bokemeyer, Annalisa Ruggeri, Elisabetta Metafuni, Matthieu Delaye, J-H Bouhris, Edward Kanfer
article en
7 citations

Abstract

To our knowledge, this is the most extensive retrospective study of HDC in PMNSGCTs patients and the first to thoroughly investigate potential predictors of benefit from this treatment. HDC with ASCT may well represent a therapeutic option in patients with PMNSGCTs after the first relapse or even as a front-line program.

ESMO OpenVol. 9(9)
Imperial College Healthcare NHS Trust (GB), Inserm (FR), Universität Hamburg (DE), University of Freiburg (DE), University of Pavia (IT), University Medical Center Freiburg (DE), Institut Gustave Roussy (FR), Agostino Gemelli University Polyclinic (IT), Sorbonne Université (FR), Assistance Publique – Hôpitaux de Paris (FR), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT), Hôpital Saint-Antoine (FR), University Medical Center Hamburg-Eppendorf (DE), Metaxa Hospital (GR), Center for Translational Molecular Medicine (NL), Centre de Recherche Saint-Antoine (FR), Mylan (Switzerland) (CH), Fraunhofer Institute for Cell Therapy and Immunology (DE), Policlinico San Matteo Fondazione (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), European Society for Blood and Marrow Transplantation (FR), Hôpital Tenon (FR)
Good health and well-being
Openalex Percentile: Top 6%
Testicular diseases and treatments
4.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.